Literature DB >> 28595533

Recent Advances of Computational Modeling for Predicting Drug Metabolism: A Perspective.

Supratik Kar1, Jerzy Leszczynski1.   

Abstract

BACKGROUND: Absorption, Distribution, Metabolism, Excretion (ADME) properties along with drug induced adverse effects are the major reasons for the late stage failure of drug candidates as well as the cause for the expensive withdrawal of many approved drugs from the market. Considering the adverse effects of drugs, metabolism factor has great importance in medicinal chemistry and clinical pharmacology because it influences the deactivation, activation, detoxification and toxification of drugs.
METHODS: Computational methods are effective approaches to reduce the number of safety issues by analyzing possible links between chemical structures and metabolism followed by adverse effects, as they serve the integration of information on several levels to enhance the reliability of outcomes. RESULTS AND DISCUSSION: In silico profiling of drug metabolism can help progress only those molecules along the discovery chain that is less likely to fail later in the drug discovery process. This positively impacts the very high costs of drug discovery and development. Understanding the science behind computational tools, their opportunities, and limitations is essential to make a true influence on drug discovery at different levels. If applied in a scientifically consequential way, computational tools may improve the capability to identify and evaluate potential drug molecules considering pharmacokinetic properties of drugs.
CONCLUSION: Herein, current trends in computational modeling for predicting drug metabolism are reviewed highlighting new computational tools for drug metabolism prediction followed by reporting large and integrated databases of approved drugs associated with diverse metabolism issues. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  ADMET; ADR; In silico; QSAR; SoM; docking; expert systems; metabolism

Mesh:

Substances:

Year:  2017        PMID: 28595533     DOI: 10.2174/1389200218666170607102104

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  6 in total

1.  In Silico Tools and Software to Predict ADMET of New Drug Candidates.

Authors:  Supratik Kar; Kunal Roy; Jerzy Leszczynski
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Computational methods and tools to predict cytochrome P450 metabolism for drug discovery.

Authors:  Jonathan D Tyzack; Johannes Kirchmair
Journal:  Chem Biol Drug Des       Date:  2019-01-15       Impact factor: 2.817

3.  A network pharmacology approach to explore and validate the potential targets of ginsenoside on osteoporosis.

Authors:  Ling Guo; Qingliu Zhen; Xiaoyue Zhen; Zhaoyang Cui; Chao Jiang; Qiang Zhang; Kun Gao; Deheng Luan; Xuanchen Zhou
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

Review 4.  Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs.

Authors:  Tyler C Beck; Kyle R Beck; Jordan Morningstar; Menny M Benjamin; Russell A Norris
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-17

5.  Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (Mpro) through docking, molecular mechanic & dynamic, and ADMET profiling.

Authors:  Karina Kapusta; Supratik Kar; Jasmine T Collins; Latasha M Franklin; Wojciech Kolodziejczyk; Jerzy Leszczynski; Glake A Hill
Journal:  J Biomol Struct Dyn       Date:  2020-08-14

6.  Computer-Aided Estimation of Biological Activity Profiles of Drug-Like Compounds Taking into Account Their Metabolism in Human Body.

Authors:  Dmitry A Filimonov; Anastassia V Rudik; Alexander V Dmitriev; Vladimir V Poroikov
Journal:  Int J Mol Sci       Date:  2020-10-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.